
In the western world, richer people tend to be thinner – especially women. But does wealth make people thin, or does being thin make them wealthy? And could the rise of weight-loss drugs such as Mounjaro and Wegovy give people – especially women – greater control over their economic outcomes? Soumaya speaks to Harvard professor Rebecca Diamond, the author of a new working paper that finds female users of GLP-1 drugs are more likely to find jobs and romantic partners. Soumaya also speaks to FT consumer editor (and GLP-1 user) Claer Barrett to discuss the drugs’ effects on consumer habits – and the economy at large.Subscribe to Soumaya's show on Apple, Spotify, Pocket Casts or wherever you listen.Further reading: The economics of women’s weightDoes the weight-loss revolution show up in the data?The challenges of a weight-loss economyPresented by Soumaya Keynes. Produced by Mischa Frankl-Duval. Original music and sound design by Breen Turner. Andrew Georgiades is the broadcast engineer. Manuela Saragosa is the executive producer. Flo Phillips if the FT's head of audio.Read a transcript of this episode on FT.com Hosted on Acast. See acast.com/privacy for more information.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

Why didn’t the Iran war cause a recession? With Tyler Goodspeed

How to win at AI (if you’re not the US or China), with AI minister Kanishka Narayan

China wanted western tech. Now, the tables have turned. With John Minnich

Brexit at 10: What comes next? With Anand Menon
Free AI-powered recaps of The Economics Show and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.